对 Pembrolizumab 有反应的霍奇金淋巴瘤支气管内表现：病例报告。

IF 2 4区医学 Q3 ONCOLOGY

Chemotherapy Pub Date : 2023-01-01 Epub Date: 2023-06-13 DOI:10.1159/000527059

Marianna Gentilini, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Marco Ferrari, Matteo Carella, Lisa Argnani, Pier Luigi Zinzani

引用次数: 0

摘要

支气管内定位的霍奇金淋巴瘤非常罕见，自 20 世纪以来，文献中鲜有相关报道。在此，我们报告了首例使用 pembrolizumab 成功治疗的复发/难治性霍奇金淋巴瘤病例，患者气管水平有临界植物性肿块。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report.

An endobronchial localization of Hodgkin lymphoma is rare, and few experiences since the 1900s have been reported in the literature. Here we report the first case of a relapsed/refractory Hodgkin lymphoma with a critical vegetative mass at the level of the trachea successfully treated with pembrolizumab.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chemotherapy 医学-药学

CiteScore

5.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.